Reposted by: Anirban Basu
Reposted by: Anirban Basu
www.healthaffairs.org/doi/10.1377/...
Reposted by: Anirban Basu, John A. Graves
https://ja.ma/3VCyjA9
Reposted by: Anirban Basu
Very well done study, cleverly measuring impact of lower cost-sharing for vulnerable patients
Reposted by: Anirban Basu, David Cutler, Andrea Manca , and 1 more Anirban Basu, David Cutler, Andrea Manca, Andrew Jones
Early career health economists not familiar with Will and his work might benefit from knowing the significant and enduring contributions Will made to our field.
onlinelibrary.wiley.com/doi/10.1002/...
by Anirban Basu
by Anirban Basu
d-nb.info/990097153/34
by Anirban Basu
by Anirban Basu
Reposted by: Anirban Basu
🚨 Opportunity for comments ends in 11 days!
@asacarny.bsky.social @basucally.bsky.social @aschwartz.bsky.social
www.cms.gov/data-researc...
Reposted by: Anirban Basu
by Anirban Basu
by Anirban Basu
Reposted by: Anirban Basu
by Anirban Basu
by Anirban Basu
by Anirban Basu
by Anirban Basu
by Anirban Basu
Reposted by: Anirban Basu
www.cdc.gov/fluview/surv...
h/t @cmyeaton.bsky.social
Reposted by: Anirban Basu
📊 Area of Expertise: Person-Level Cost-Effectiveness Analysis
🔬 Research Focus: Net Benefit Regression
Since joining in 2008, Jeffrey has benefited from the society’s cutting-edge research, professional development opportunities, and expert network.
by Anirban Basu
Reposted by: Anirban Basu
@basucally.bsky.social, Jing (jingliuw.wixsite.com/mysite) & I link experimental and admin data to show that less altruistic physicians receive higher industry payments and respond more to financial incentives in prescribing:
by Anirban Basu
Reposted by: Anirban Basu
by Anirban Basu
by Anirban Basu
I return, I hope total NIH budget is raised by at least that much & certain F&A items allowed to be budgeted under direct costs with justification!
by Anirban Basu
www.nber.org/papers/w32258
by Anirban Basu
www.nytimes.com/2025/02/07/o...
Reposted by: Anirban Basu
www.nytimes.com/2025/02/07/o...